Thursday, October 15, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 28, 2026

Montrose Environmental Group Q4 Earnings Call Highlights

View original at finance.yahoo.com
Montrose Environmental Group Q4 Earnings Call Highlights Montrose Environmental Group logo Key Points Montrose reported a "record" 2025 with revenue of $830.5 million and consolidated adjusted EBITDA of $116.2 million, and set 2026 guidance of $840–$900 million in revenue and $125–$130 million in adjusted EBITDA (imply…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • 2025 was the strongest year in the company's history

    80% confidence

  • Approximately 90% of Montrose's clients operate in private-sector industries and U.S. federal government exposure is less than 3% of revenue

    80% confidence

  • No M&A deals appear imminent in Q1 or early Q2, with potential bolt-on activity more likely in back half of 2026

    80% confidence

  • Remediation and Reuse margins expected to improve in 2026 as water treatment grows and operating leverage increases

    80% confidence

  • Recent U.S. EPA methane framework changes are not expected to have a material near-term impact on Montrose's services

    80% confidence

  • Fourth-quarter revenue rose to $193.3 million from $189.1 million a year earlier

    80% confidence

  • Measurement and Analysis margins expected to remain elevated though modestly lower than 2025

    80% confidence

  • Company expects APR segment margins to strengthen in 2026 due to demand, pricing discipline, and operational efficiency

    80% confidence

  • Quarterly margin decline attributed to lower margins in Measurement and Analysis and Remediation and Reuse, plus expenses tied to winding down renewables business

    80% confidence

  • M&A opportunities identified in testing and consulting across Australia, Canada, and the U.S.

    80% confidence

  • Organic growth of 12.7% exceeded long-term target of 7% to 9%

    80% confidence

  • Water treatment total addressable market is more than $250 billion

    80% confidence

  • Company is targeting 60% operating cash conversion in 2026, above long-term 50%+ target

    80% confidence

  • Montrose is a water technology business with opportunities broader than PFAS

    80% confidence

  • Company expects to generate approximately $180 million in cumulative operating cash flow across 2025 and 2026

    80% confidence

  • PFAS-related revenue remains about 10% to 15% of the business, with double-digit growth expected into 2026

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com
Montrose Environmental Group Q4 Earnings Call Highlights — Source | Via News | Via News